A disease-modifying therapy for retinal degenerations by drug repurposing

被引：0

作者：

Leinonen, Henri Olavi ^{[1
,2
]}

Zhang, Jianye ^{[1
,2
]}

Gao, Fangyuan ^{[1
,2
]}

Choi, Elliot H. ^{[1
,2
]}

Einstein, Elliott E. ^{[3
]}

Einstein, David E. ^{[4
]}

Occelli, Laurence Mireille ^{[5
]}

Marinho, Luis Felipe ^{[5
]}

Kolesnikov, Alexander V. ^{[6
]}

Kefalov, Vladimir ^{[6
]}

Skowronska-Krawczyk, Dorota ^{[1
,2
]}

Blackshaw, Seth ^{[7
]}

Petersen-Jones, Simon M. ^{[5
]}

Palczewski, Krzysztof ^{[1
,2
]}

机构：

[1] Univ Calif Irvine, Ophthalmol, Irvine, CA USA

[2] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA

[3] Univ Calif Irvine, Sch Biol Sci, Irvine, CA USA

[4] Univ Calif Irvine, Physiol Biophys, Irvine, CA USA

[5] Michigan State Univ, Coll Vet Med, Small Anim Clin Sci, E Lansing, MI 48824 USA

[6] Washington Univ, Ophthalmol & Visual Sci, St Louis, MO 63110 USA

[7] Johns Hopkins Univ, Neurosci, Baltimore, MD USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

3157

引用

页数：4

共 50 条

[41] Disease-modifying effects of ranibizumab for central retinal vein occlusion
Huang, Jason M.
Khurana, Rahul N.
Ghanekar, Avanti
Wang, Pin-wen
Day, Bann-Mo
Blodi, Barbara A.
Domalpally, Amitha
Quezada-Ruiz, Carlos
Ip, Michael S.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (03) : 799 - 805
[42] Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis
Suarez-Almazor, Maria E.
Berrios-Rivera, Javier P.
Cox, Vanessa
Janssen, Namieta M.
Marcus, Donald M.
Sessoms, Sandra
JOURNAL OF RHEUMATOLOGY, 2007, 34 (12) : 2400 - 2407
[43] Tocilizumab as an invaluable disease-modifying drug in neuromyelitis optica
Araki, M.
Matsuoka, T.
Miyamoto, K.
Kusunoki, S.
Murata, M.
Yamamura, T.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 74 - 75
[44] Amisulpride as a potential disease-modifying drug in the treatment of tauopathies
Jahreis, Kathrin
Bruege, Alina
Borsdorf, Saskia
Mueller, Franziska E.
Sun, Weilun
Jia, Shaobo
Kang, Dong Min
Boesen, Nicolette
Shin, Seulgi
Lim, Sungsu
Koroleva, Anastasia
Satala, Grzegorz
Bojarski, Andrzej J.
Rakusa, Elena
Fink, Anne
Doblhammer-Reiter, Gabriele
Kim, Yun Kyung
Dityatev, Alexander
Ponimaskin, Evgeni
Labus, Josephine
ALZHEIMERS & DEMENTIA, 2023, 19 (12) : 5482 - 5497
[45] Psilocybin as a Disease-Modifying Drug A Salutogenic Approach in Psychiatry
Spangemacher, Moritz
Mertens, Lea J.
Faerber, Luca V.
Jungaberle, Andrea
Jungaberle, Henrik
Gruender, Gerhard
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2024, 121 (26):
[46] The quest for the Holy Grail: a disease-modifying osteoarthritis drug
Francis Berenbaum
Arthritis Research & Therapy, 9
[47] Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy
Akkoc, Nurullah
van der Linden, Sjef
Khan, Muhammad Asim
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (03): : 539 - 557
[48] The quest for the Holy Grail: a disease-modifying osteoarthritis drug
Berenbaum, Francis
ARTHRITIS RESEARCH & THERAPY, 2007, 9 (06)
[49] Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease
Musiek, Erik S.
Morris, John C.
JAMA NEUROLOGY, 2021, 78 (02) : 141 - 142
[50] Alzheimer disease: From basic study to disease-modifying therapy
Iwatsubo, Takeshi
NEUROSCIENCE RESEARCH, 2009, 65 : S4 - S4

← 1 2 3 4 5 →